Meropenem Sun (Meropenem)

Meropenem is indicated for severe infections caused by susceptible bacteria across several organ systems.

• Complicated intra‑abdominal infections: effective in reducing bacterial load and improving clinical outcomes.
• Complicated urinary tract infections: eradicates pathogens causing pyelonephritis and cystitis.
• Bacterial meningitis: achieves therapeutic concentrations in cerebrospinal fluid to treat meningitis.
• Hospital‑acquired pneumonia: combats resistant Gram‑negative organisms in ventilated patients.
• Skin and soft tissue infections: resolves infections caused by mixed aerobic and anaerobic bacteria.
• Febrile neutropenia: provides broad‑spectrum coverage for immunocompromised patients.

• Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. The drug exhibits broad activity against many Gram‑negative, Gram‑positive, and anaerobic organisms, including those resistant to other β‑lactam classes.

Meropenem may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools, occasionally watery.
• Rash: mild skin erythema or pruritus.
• Headache: transient cephalic discomfort.
• Infusion site reactions: erythema, pain, or phlebitis at the injection site.
• Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or CNS disorders.
• Clostridioides difficile colitis: severe diarrhea due to bacterial overgrowth.
• Anaphylaxis: acute, potentially life‑threatening allergic reaction.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Renal toxicity: acute kidney injury in predisposed individuals.

When using Meropenem, clinicians should observe the following precautions to ensure safe and effective therapy.

• Renal impairment: adjust dose based on creatinine clearance.
• Hypersensitivity: discontinue if allergic reactions occur.
• Seizure risk: monitor patients with CNS disorders or high doses.
• Pregnancy and lactation: use only if benefit outweighs potential risk.
• Concomitant nephrotoxic drugs: monitor renal function closely.
• Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Meropenem can interact with other medicines; awareness of significant interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Valproic acid: carbapenems reduce serum valproate levels, increasing seizure risk.
• Other carbapenems: additive toxicity, avoid concurrent use.
• High‑dose aminoglycosides: increased nephrotoxicity risk.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may enhance renal clearance, monitor electrolytes.
• Warfarin: potential alteration of INR, check coagulation parameters.
• Oral contraceptives: reduced efficacy, advise alternative contraception.
• NSAIDs: increased risk of renal impairment, monitor kidney function.